Zobrazeno 21 - 30
of 40
pro vyhledávání: '"Normanno N"'
Autor:
Andrea Onetti Muda, Guido Giordano, Gianni Simone, Pietro Micheli, C. Barone, Giacomo Cartenì, Fabiana Tatangelo, Laura Longhitano, Vincenzo Rosario Iaffaioli, Alessandra Cassano, M. Biglietto, Anna Nappi, Sabrina Rossi, A.R. Bordonaro, A. Rinaldi, Francesco Sponziello, G. Modoni, GabrieleDi Maggio, Matilde Lambiase, Oscar Nappi, Claudia Cardone, Antonella Marino, Mirko Montrone, Sandro Barni, Michele Orditura, Antonio Febbraro, Paolo Graziano, Saverio Cinieri, Guglielmo Nasti, Fortunato Ciardiello, Evaristo Maiello, D. Rizzi, Vincenzo Sforza, Stefano Cordio, F. De Vita, Erika Martinelli, S. Romito, Vincenzo Montesarchio, Giuseppe Tonini, Annamaria Sebastio, Salvatore Pisconti, Nicola Normanno, Tiziana Guarino, Giuseppe Colucci, Francesco Giuliani, Anna Maria Rachiglio, Gerardo Botti, Nicoletta Chicchinelli, Tiziana Latiano, Teresa Troiani, Vito Lorusso, Michele Aieta, Silvana Leo, Giuseppe Grimaldi, Eugenio Tommaselli, Luigi Leo, Cinzia Chiarazzo, Mario Manusia
Publikováno v:
ESMO Open
In the cetuximab after progression in KRAS wild-type colorectal cancer patients (CAPRI) trial patients with metastatic colorectal cancer (mCRC) received 5-fluorouracil, folinic acid and irinotecan (FOLFIRI) and cetuximab in first line followed by 5-F
Autor:
Francesco Perrone, Simona Bevilacqua, Agnese Montanino, Simona Signoriello, Cesare Gridelli, Ciro Gallo, Massimo Di Maio, Antonio Rossi, Antonella De Luca, Gaetano Rocco, Raffaele Costanzo, Nicola Normanno, Alessandro Morabito
Publikováno v:
Lung Cancer. 85:314-319
Objectives Circulating tumor cells (CTCs) have been hypothesized to be a prognostic factor in small-cell lung cancer (SCLC), and different cutoffs have been proposed to identify patients at high risk. We assessed the prognostic value of CTCs in patie
Autor:
Giovanna Finocchiaro, Filippo de Marinis, Marcello Tiseo, Giulio Cerea, Alessandro Del Conte, Laura Giannetta, Maria Rita Migliorino, Rita Chiari, Marco Angelo Burgio, Francesca Mazzoni, Agnese Montanino, Alessandro Morabito, Federico Cappuzzo, Nicola Normanno, Roberta Buosi, Paolo Bidoli, Diego Cortinovis, Luisa Foltran, Silvia Ferrari
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 99
Objectives Although patients with advanced non-small cell lung cancer (NSCLC) and an activating epidermal growth factor receptor (EGFR) mutation benefit from the use of EGFR-tyrosine kinase inhibitors (TKI), most of them progress within 12 months fro
Autor:
R. Labianca, Fortunato Ciardiello, J.-Y. Douillard, Alfredo Falcone, André D'Hoore, C.-H. Köhne, Aziz Zaanan, George Pentheroudakis, Dan Aderka, Nicola Normanno, Takayuki Yoshino, Per Pfeiffer, H.-J. Schmoll, Al B. Benson, J.H.J.M. van Krieken, René Adam, Demetris Papamichael, Paulo M. Hoff, Jens Ricke, R. Salazar, György Bodoky, Harpreet Wasan, Josep Tabernero, Timothy J. Price, Dirk Arnold, Michel Ducreux, Alberto Sobrero, Thomas Gruenberger, Brigette B.Y. Ma, Axel Grothey, E. Aranda Aguilar, E. Van Cutsem, Karin Haustermans, Volker Heinemann, Pia Österlund, Kei Muro, Arnaud Roth, Eduardo Díaz-Rubio, Pierre Laurent-Puig, Andrés Cervantes, Alberto Bardelli, Wim J.G. Oyen, Julien Taieb, C.J.A. Punt, Sabine Tejpar, Tim Maughan, Werner Scheithauer
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Annals of Oncology, 27, 1386-422
Van Cutsem, E, Cervantes, A, Adam, R, Sobrero, A, Van Krieken, J H, Aderka, D, Aranda Aguilar, E, Bardelli, A, Benson, A, Bodoky, G, Ciardiello, F, D'Hoore, A, Diaz-Rubio, E, Douillard, J-Y, Ducreux, M, Falcone, A, Grothey, A, Gruenberger, T, Haustermans, K, Heinemann, V, Hoff, P, Köhne, C-H, Labianca, R, Laurent-Puig, P, Ma, B, Maughan, T, Muro, K, Normanno, N, Österlund, P, Oyen, W J G, Papamichael, D, Pentheroudakis, G, Pfeiffer, P, Price, T J, Punt, C, Ricke, J, Roth, A, Salazar, R, Scheithauer, W, Schmoll, H J, Tabernero, J, Taïeb, J, Tejpar, S, Wasan, H, Yoshino, T, Zaanan, A & Arnold, D 2016, ' ESMO consensus guidelines for the management of patients with metastatic colorectal cancer ', Annals of Oncology, vol. 27, no. 8, pp. 1386-1422 . https://doi.org/10.1093/annonc/mdw235
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Annals of Oncology, 27, 8, pp. 1386-422
Annals of oncology, 27(8), 1386-1422. Oxford University Press
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Annals of Oncology, 27, 1386-422
Van Cutsem, E, Cervantes, A, Adam, R, Sobrero, A, Van Krieken, J H, Aderka, D, Aranda Aguilar, E, Bardelli, A, Benson, A, Bodoky, G, Ciardiello, F, D'Hoore, A, Diaz-Rubio, E, Douillard, J-Y, Ducreux, M, Falcone, A, Grothey, A, Gruenberger, T, Haustermans, K, Heinemann, V, Hoff, P, Köhne, C-H, Labianca, R, Laurent-Puig, P, Ma, B, Maughan, T, Muro, K, Normanno, N, Österlund, P, Oyen, W J G, Papamichael, D, Pentheroudakis, G, Pfeiffer, P, Price, T J, Punt, C, Ricke, J, Roth, A, Salazar, R, Scheithauer, W, Schmoll, H J, Tabernero, J, Taïeb, J, Tejpar, S, Wasan, H, Yoshino, T, Zaanan, A & Arnold, D 2016, ' ESMO consensus guidelines for the management of patients with metastatic colorectal cancer ', Annals of Oncology, vol. 27, no. 8, pp. 1386-1422 . https://doi.org/10.1093/annonc/mdw235
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Annals of Oncology, 27, 8, pp. 1386-422
Annals of oncology, 27(8), 1386-1422. Oxford University Press
Contains fulltext : 165965.pdf (Publisher’s version ) (Closed access) Colorectal cancer (CRC) is one of the most common malignancies in Western countries. Over the last 20 years, and the last decade in particular, the clinical outcome for patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07ccf2b801d4b95d9bd0bb5c50736ce1
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=3106
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=3106
Autor:
Francesco Sponziello, Saverio Cinieri, Giuseppe Grimaldi, Alessandra Cassano, M. Biglietto, Pietro Micheli, Gianni Simone, C. Barone, Fabiana Tatangelo, Antonella Marino, Giacomo Cartenì, Guglielmo Nasti, D. Rizzi, Antonio Febbraro, Cinzia Chiarazzo, Mario Manusia, Vito Lorusso, Fortunato Ciardiello, A.R. Bordonaro, S. Romito, Sabrina Rossi, Teresa Troiani, F. De Vita, Eugenio Tommaselli, Giuseppe Colucci, Andrea Onetti Muda, Guido Giordano, Luigi Leo, G. Modoni, Annamaria Sebastio, Sandro Barni, Francesco Giuliani, Paolo Graziano, M. Rachiglio, Michele Aieta, Evaristo Maiello, Enrica Martinelli, Mirko Montrone, Silvana Leo, Tiziana Latiano, Stefano Cordio, Laura Longhitano, Vincenzo Rosario Iaffaioli, Vincenzo Montesarchio, Nicola Normanno, Anna Nappi, Matilde Lambiase, Gerardo Botti, Gabriele Di Maggio, Giuseppe Tonini, Nicoletta Chicchinelli, Oscar Nappi, Claudia Cardone, Michele Orditura, A. Rinaldi, Salvatore Pisconti, Tiziana Guarino
Background Cetuximab plus chemotherapy is a first-line treatment option in metastatic KRAS and NRAS wild-type colorectal cancer (CRC) patients. No data are currently available on continuing anti-epidermal growth factor receptor (EGFR) therapy beyond
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::343fea2703fb6409297f48937f6f6bde
http://hdl.handle.net/11591/354385
http://hdl.handle.net/11591/354385
Autor:
Giuseppe Perrone, Mario Manusia, Erika Martinelli, Eugenio Tommaselli, Salvatore Pisconti, A. Perrino, M. Biglietto, Giuseppe Colucci, A. Cardarelli, A. Onetti Muda, Francesco Giuliani, Guido Rindi, Guglielmo Nasti, D. Rizzi, Anna Maria Rachiglio, Saverio Cinieri, Evaristo Maiello, Antonio Febbraro, Fortunato Ciardiello, Gianni Simone, Giacomo Cartenì, E. Montesarchio, Matilde Lambiase, Fabiana Tatangelo, Teresa Troiani, Nicola Normanno, G. Botti, Daniela Cabibi, A. Rinaldi, Alessia Iannaccone, Pietro Micheli, C. Barone, Oscar Nappi, Antonio Russo, Cristin Roma, Roberto Bordonaro, Claudia Esposito, Annamaria Sebastio, Francesca Fenizia, Paolo Graziano, S. Romito, Giuseppe Tonini, Pantaleo Bufo, Tiziana Latiano, Nicoletta Chicchinelli, P. Giaccone, M. Criscuolo
Background: Evidence suggests that metastatic colorectal carcinoma (mCRC) has a high level of intratumor heterogeneity. We carried out a quantitative assessment of tumor heterogeneity for KRAS, NRAS, BRAF and PIK3CA mutations, in order to assess pote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e00a8ef70d693dea7a745c8bef2ef289
http://hdl.handle.net/10447/295526
http://hdl.handle.net/10447/295526
Autor:
Giuseppe Pirozzi, A. La Rocca, Rosalba Camerlingo, Nicola Martucci, Virginia Tirino, Giosuè Scognamiglio, Renato Franco, Gaetano Rocco, Nicola Normanno, Monica Cantile
The epithelial-mesenchymal transition (EMT) is a program involved in embryonic development that is often activated during cancer invasion and metastasis. CD133 is the main marker identifying cancer stem cells (CSCs) in lung cancer. Circulating tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbc919bce893d1d719938ad05bfa443f
http://hdl.handle.net/11591/183265
http://hdl.handle.net/11591/183265
Autor:
G. Buonfanti, Ciro Gallo, A. De Matteis, Simona Signoriello, Vincenza Tinessa, Alessandro Morabito, F. Perrone, Mauro Piccirillo, Carmen Pacilio, Gennaro Daniele, E. De Maio, M. De Laurentiis, Roberta D’Aniello, G. Botti, Giuseppe Esposito, F. Di Rella, G. Landi, Elisa Rossi, Massimiliano D’Aiuto, M. Di Bonito, Nicola Normanno, G. De Feo, A. Bartiromo, G. Colantuoni, Secondo Lastoria, Piera Maiolino, M. Di Maio, V. Labonia, Pasqualina Giordano, Adriano Gravina, Francesco Nuzzo
BACKGROUND To measure bone mineral density (BMD) reduction produced by letrozole as compared with tamoxifen and the benefit of the addition of zoledronic acid. PATIENTS AND METHODS A phase 3 trial comparing tamoxifen, letrozole or letrozole+zoledroni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e36da332b666974bbc5593e0d069612
http://hdl.handle.net/11588/467894
http://hdl.handle.net/11588/467894
Publikováno v:
Breast Cancer Research and Treatment. 29:11-27
A number of different epidermal growth factor (EGF)-related peptides such as EGF, transforming growth factor alpha (TGF alpha), amphiregulin (AR), heregulin (HRG), and cripto-1 (CR-1), are coexpressed to varying degrees in both normal and malignant m
Autor:
Sabine Tejpar, Eric Van Cutsem, Bruno Wohlschlegel, Domenica Mercadante, Nicola Normanno, T. Teague, Fortunato Ciardiello
Publikováno v:
Targeted oncology. 6(3)
The mutation status of the KRAS gene in the tumors of patients with metastatic colorectal cancer (mCRC) is a predictive biomarker for the efficacy of epidermal growth factor receptor monoclonal antibody therapy. The establishment of KRAS mutation tes